Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/11774
Type
ArticleCopyright
Open access
Collections
- IOC - Artigos de Periódicos [12968]
Metadata
Show full item record
DENGUE INDUCES PLATELET ACTIVATION, MITOCHONDRIAL DYSFUNCTION AND CELL DEATH THROUGH MECHANISMS THAT INVOLVE DC-SIGN AND CASPASES
Author
Affilliation
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Instituto de Pesquisa Clinica Evandro Chagas. Rio de Janeiro, RJ, Brasil /
Universidade Federal do Rio de Janeiro. Instituto de Bioquíımica Médica. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Flavivírus. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Flavivírus. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Universidade Federal do Rio de Janeiro. Instituto de Bioquíımica Médica. Rio de Janeiro, RJ, Brasil.
University of Utah. The Molecular Medicine Program. Department of Medicine. Salt Lake City, UT, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Universidade Federal do Rio de Janeiro. Instituto de Bioquíımica Médica. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Flavivírus. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Flavivírus. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Universidade Federal do Rio de Janeiro. Instituto de Bioquíımica Médica. Rio de Janeiro, RJ, Brasil.
University of Utah. The Molecular Medicine Program. Department of Medicine. Salt Lake City, UT, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunofarmacologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Abstract
Background: Worldwide, dengue is the most
prevalent human arbovirus disease. Dengue infection may
cause a range of clinical manifestations from self-limiting
febrile illness through to a life-threatening syndrome
accompanied by both bleeding and shock. Thrombocytopenia
is frequently observed in mild and severe disease; however,
the mechanisms involved in DENV-induced platelet
activation and thrombocytopenia are incompletely understood.
Patients and methods: Freshly isolated platelets from
patients with dengue were evaluated for markers of activation,
mitochondrial alteration and activation of cell death
pathways. In parallel, we examined direct DENV-induced
activation and apoptosis of platelets obtained from healthy
subjects. Results: We found that platelets from DENVinfected
patients exhibited increased activation by comparison
to control subjects. Moreover, platelets from DENVinfected
patients exhibited classic signs of the intrinsic
pathway of apoptosis that include increased surface phosphatidylserine
exposure, mitochondrial depolarization and
activation of caspase-9 and -3. Indeed, thrombocytopenia
was shown to strongly associate with enhanced platelet
activation and cell death in DENV-infected patients. Platelet
activation, mitochondrial dysfunction and caspasedependent
phosphatidylserine exposure on platelets were
also observed when platelets from healthy subjects were
directly exposed to DENV in vitro. DENV-induced platelet
activation was shown to occur through mechanisms largely
dependent on DC-SIGN. Conclusions: : Together our
results demonstrate that platelets from patients with dengue
present signs of activation, mitochondrial dysfunction
and activation of the apoptosis caspase cascade, which may
contribute to the development of thrombocytopenia in
patients with dengue. Our results also suggest the involvement
of DC-SIGN as a critical receptor in DENV-dependent
platelet activation.
Share